Zhongnan Medical Journal Press

Home Results

A total of 2057 result was found. Results that relate to R

Efficacy and safety of tegoprazan in the treatment of gastroesophageal reflux disease: a systematic review and Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1294-1301.
2454 times 486 times

LU Ronghua LIU Jiaojiao PANG Tengfei CAI Rui YUAN Jian

Tegoprazan Gastroesophageal reflux disease Meta-analysis Systematic review Randomized controlled trial
Details
Toripalimab for the treatment of advanced esophageal cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1302-1310.
1878 times 360 times

YANG Shou NIE Ying GONG Yuan KANG Shuo HOU Yibing WANG Xiaohui PAN Zhenhua

Toripalimab Advanced esophageal cancer Rapid health technology assessment Effectiveness Safety Economy
Details
Rapid health technology assessment of avatrombopag for the treatment of primary immune thrombocytopenia in adults

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1311-1319.
1931 times 358 times

LI Zhou LING Ya ZHANG Jie ZHU Ling

Avatrombopag Primary immune thrombocytopenia Efficacy Safety Economy Rapid health technology assessment
Details
Research advances in adverse drug reactions and their management in targeted therapy for driver gene-positive advanced non-small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1320-1329.
1977 times 358 times

FAN Jiameng PAN Lei

Non-small cell lung cancer Target therapy Adverse drug reactions Symptom management Biomarker
Details
Pharmaceutical care for a case of abemaciclib-induced interstitial lung disease

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1330-1334.
1821 times 347 times

DING Liping WU Wei WANG Chunhui

Abemaciclib Interstitial lung disease Breast cancer Pharmaceutical care
Details
Pharmaceutical practice of bevacizumab-induced refractory hypertension and proteinuria in a patient with advanced lung adenocarcinoma

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1335-1339.
1859 times 346 times

YAN Jiaju YUAN Yongyong LIU Meng

Bevacizumab Lung adenocarcinoma Resistant hypertension Proteinuria Phamaceutical care
Details
Anti-infection treatment and pharmaceutical care for a patient with liver cirrhosis complicated with severe psittacosis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1340-1346.
1971 times 362 times

XING Baiqian LIU Hunan SUN Yihong LU Nianfang LI Zhongdong

Liver cirrhosis Chlamydia psittaci Omadacycline Voriconazole Posaconazole Pharmaceutical care
Details
Acute drug-induced liver injury associated with tolvaptan in a patient with cardiac amyloidosis: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1347-1352.
1966 times 344 times

YAO Tingyi ZHANG Weixia

Tolvaptan Drug-induced liver injury AL cardiac amyloidosis Heart failure
Details
Investigation and implementation exploration on knowledge, attitude and practice of influenza vaccination among college students

Published on New Medicine 2025,35(11):1249-1255.
2518 times 490 times

XUE Lijia NIE Ying WANG Wei WANG Lu LIU Hongjun LUO Shihuan LI Nan ZOU Xinyu LI Sheyu LUO Li

Influenza Vaccination College students Knowledge attitude and practice Influencing factors
Details
Association of sleep duration and sleep quality with metabolic associated fatty liver disease among Wuhan subway workers

Published on New Medicine 2025,35(11):1256-1264.
2246 times 417 times

PENG Rong LIU Junling SHI Bin TAO Yi YAN Xueping HE Zhenyu

Sleep duration Sleep quality Metabolic associated fatty liver disease Mediation effect
Details
Research on the awareness and needs of scientific and technological achievements transformation in tertiary public hospitals in Shanghai

Published on New Medicine 2025,35(11):1265-1271.
2386 times 433 times

SUN Lu LI Huiyi SHAN Qiyuan ZHANG Xinyi XU Zengguang

Tertiary public hospitals Technology transfer Transfer awareness Transfer demand Patent transformation
Details
Prediction and analysis of red blood cells clinical demand based on the ARIMA model

Published on New Medicine 2025,35(11):1272-1278.
2158 times 393 times

YANG Xu LIU Shuqi HUANG Hui CHEN Xiulan LOU Yiling CAO Shiyi JIANG Qingqing

Red blood cell ARIMA multiplicative seasonal model Demand forecasting Health management
Details
The distribution of RhCE phenotypes and molecular genetic background of D variants in preliminary screening of RhD-negative blood donors

Published on New Medicine 2025,35(11):1279-1285.
2203 times 391 times

ZHANG Xia ZHAO Gaowei FENG Zhihui GUO Ming

RhD negative RhCE phenotype D variant
Details
Construction and validation of a prediction model for postmenopausal asymptomatic endometrial thickening

Published on New Medicine 2025,35(11):1286-1293.
2943 times 376 times

XU Yan YANG Tingting MA Chenglei ZHAO Fang MA Xin

Endometrial thickening Risk factors Nomogram Predictive model
Details
Assessment of current status and influencing factors of financial toxicity among elderly hypertensive patients in rural Zhuzhou

Published on New Medicine 2025,35(11):1294-1302.
2129 times 383 times

ZHANG Zhen WEI Shiyi TIAN Yanzhen WU Yanxian WANG Lang ZHANG Shiji FENG Nina

Elderly hypertension Financial toxicity Self-management behavior Influencing factors Random forest model
Details